ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.604
-0.03%
Brent Oil
83.815
0.07%
Bitcoin
66,297.92
-0.96%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Panacea Acquisition Corp (NUVB)

  7. Panacea Acquisition Corp (NUVB) Noticias

NUVB

Panacea Acquisition (NUVB)

Panacea Acquisition Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:NUVB
FechaHoraFuenteTítuloSímboloCompañía
14/05/202415:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
14/05/202415:20Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
14/05/202415:05Business WireNuvation Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
24/04/202409:01Business WireNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:NUVBPanacea Acquisition Corp
10/04/202415:01Business WireNuvation Bio Completes Acquisition of AnHeart TherapeuticsNYSE:NUVBPanacea Acquisition Corp
28/03/202407:00Business WireNuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerNYSE:NUVBPanacea Acquisition Corp
25/03/202406:00Business WireNuvation Bio to Acquire AnHeart Therapeutics in All-Stock TransactionNYSE:NUVBPanacea Acquisition Corp
14/03/202415:05Business WireNuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
04/03/202416:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NUVBPanacea Acquisition Corp
04/03/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
29/02/202416:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:NUVBPanacea Acquisition Corp
29/02/202415:01Business WireNuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
10/01/202415:21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
08/01/202415:58Dow Jones NewsNuvation Bio Gets New Drug Application Clearance From FDA for Solid Tumor TreatmentNYSE:NUVBPanacea Acquisition Corp
08/01/202415:10Business WireNuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of DirectorsNYSE:NUVBPanacea Acquisition Corp
08/01/202415:05Business WireNuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
13/11/202315:05Business WireNuvation Bio Announces Departure of Chief Financial OfficerNYSE:NUVBPanacea Acquisition Corp
02/11/202315:10Business WireNuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
03/08/202315:10Business WireNuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
01/06/202315:05Business WireNuvation Bio Announces Formation of Oncology-Focused Scientific Advisory BoardNYSE:NUVBPanacea Acquisition Corp
17/05/202316:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NUVBPanacea Acquisition Corp
16/05/202315:04Edgar (US Regulatory)Current Report Filing (8-k)NYSE:NUVBPanacea Acquisition Corp
04/05/202315:33Edgar (US Regulatory)Quarterly Report (10-q)NYSE:NUVBPanacea Acquisition Corp
04/05/202315:05Business WireNuvation Bio Reports First Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
11/04/202315:27Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:NUVBPanacea Acquisition Corp
04/04/202315:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:NUVBPanacea Acquisition Corp
15/03/202315:05Business WireNuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
14/02/202307:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NUVBPanacea Acquisition Corp
13/02/202311:50Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:NUVBPanacea Acquisition Corp
19/12/202215:05Business WireNuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868NYSE:NUVBPanacea Acquisition Corp
 Showing the most relevant articles for your search:NYSE:NUVB

Su Consulta Reciente

AMEX
SVIX
1x Short VIX Futures ETF
EU
LEBL
Lcx Leblanc Chr
NASDAQ
FTTKPX
Financials Select Portfo...
LSE
87CI
Arkle 1as
ASX
DCX
DiscovEx Resources
NYSE
TNP
Tsakos Energy Navigation
TG
JPJG
JPMorgan Funds
COIN
PETHETH
Pooled Ether
LSE
OXE
TG
4JZ2
SPDR Series
COIN
BFTTTUST
Brazil National Football Team Fa
LSE
RH55
Snb Fund 27
BIT
UB25W1
UniCredit Bank
LSE
BR63
Saudi.e.suk 53
USOTC
TVAHF
TV Asahi (PK)
POLO
OXUSDT
Open Exchange Token
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados